We are live on ! Find out more
ORCL icon

Oracle

3,475 hedge funds and large institutions have $178B invested in Oracle in 2026 Q1 according to their latest regulatory filings, with 209 funds opening new positions, 1,509 increasing their positions, 1,413 reducing their positions, and 430 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% more repeat investments, than reductions

Existing positions increased: 1,509 | Existing positions reduced: 1,413

1.36% less ownership

Funds ownership: 43.4%42.04% (-1.4%)

8% less funds holding

Funds holding: 3,7603,475 (-285)

22% less call options, than puts

Call options by funds: $13B | Put options by funds: $16.7B

27% less capital invested

Capital invested by funds: $243B → $178B (-$65.2B)

29% less funds holding in top 10

Funds holding in top 10: 10776 (-31)

51% less first-time investments, than exits

New positions opened: 209 | Existing positions closed: 430

Holders
3,475
Holders Change
-285
Holders Change %
-7.58%
% of All Funds
42.72%
Holding in Top 10
76
Holding in Top 10 Change
-31
Holding in Top 10 Change %
-28.97%
% of All Funds
0.93%
New
209
Increased
1,509
Reduced
1,413
Closed
430
Calls
$13B
Puts
$16.7B
Net Calls
-$3.73B
Net Calls Change
+$1.68B
Name Holding Trade Value Shares
Change
Change in
Stake
GCS
3476
Gordian Capital (Singapore)
Singapore
$147
Norges Bank
3477
Norges Bank
Norway
-$4.34B -22,246,323 Closed
Coatue Management
3478
Coatue Management
New York
-$865M -4,440,008 Closed
PAM
3479
PineStone Asset Management
Quebec, Canada
-$351M -1,800,309 Closed
FAF
3480
Första AP-fonden
Sweden
-$92.9M -476,660 Closed
Westfield Capital Management
3481
Westfield Capital Management
Massachusetts
-$92.5M -474,397 Closed
CM
3482
Corvex Management
New York
-$78.6M -403,200 Closed
SRIM
3483
Saratoga Research & Investment Management
California
-$67.4M -345,704 Closed
SCS
3484
Syquant Capital SAS
France
-$57.5M -295,000 Closed
KCMH
3485
Keywise Capital Management (HK)
Hong Kong
-$48.2M -247,300 Closed
SCM
3486
Suvretta Capital Management
New York
-$44.1M -226,318 Closed
OCM
3487
Ogborne Capital Management
California
-$20.7M -184,985 Closed
AI
3488
Axiom Investors
Connecticut
-$31.6M -162,149 Closed
MCP
3489
Meridiem Capital Partners
Texas
-$30.6M -157,088 Closed
CCMIC
3490
Cardinal Capital Management Inc (Canada)
Manitoba, Canada
-$35.8M -133,990 Closed
Parallax Volatility Advisers
3491
Parallax Volatility Advisers
California
-$20.5M -125,989 Closed
Voloridge Investment Management
3492
Voloridge Investment Management
Florida
-$24.2M -124,360 Closed
MCM
3493
Massar Capital Management
Connecticut
-$24.2M -124,257 Closed
BCM
3494
Benchstone Capital Management
New York
-$19.8M -101,498 Closed
CCM
3495
CloudAlpha Capital Management
Hong Kong
-$19.7M -101,110 Closed
MMA
3496
Mizuho Markets Americas
New York
-$19.5M -100,000 Closed
SI
3497
Sora Investors
Pennsylvania
-$19.1M -98,247 Closed
BTCPP
3498
Border to Coast Pensions Partnership
United Kingdom
-$17.1M -87,811 Closed
MS
3499
Maven Securities
Jersey
-$14.1M -86,981 Closed
OCAM
3500
Owl Creek Asset Management
New York
-$14.1M -72,287 Closed

ORCL Hedge Fund Activity: Q1 2026 in Review

3,475 of the 8,134 institutional investors tracked by Wall St. Rank reported a position in Oracle (ORCL) for Q1 2026, worth a combined $178B — down 27% from $243B a quarter earlier.

Sellers outnumbered buyers: 430 funds closed out of ORCL and 209 opened new positions — a net loss of 221 holders — while 1,413 trimmed existing stakes and 1,509 added.

The largest buyer was BNP Paribas Financial Markets, adding an estimated $803M. The largest seller was JP Morgan Chase, cutting an estimated $1.42B.

  • 3,475 institutional investors held Oracle (ORCL) as of Q1 2026, down from 3,760 in Q4 2025.
  • Funds reported $178B of Oracle stock for Q1 2026, down 27% quarter-over-quarter.
  • 209 funds opened new Oracle positions in Q1 2026 and 430 closed out, a net change of -221 holders.
  • The largest Oracle buyer in Q1 2026 was BNP Paribas Financial Markets, an estimated $803M added.
  • The largest Oracle seller in Q1 2026 was JP Morgan Chase, an estimated $1.42B sold.

Based on aggregated 13F filings for Q1 2026.